Vivos Inc. (OTCMKTS:RDGL) Short Interest Update

Vivos Inc. (OTCMKTS:RDGL - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 93,600 shares, an increase of 1,513.8% from the February 13th total of 5,800 shares. Based on an average trading volume of 3,207,700 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company's stock are sold short.

Vivos Price Performance

Shares of RDGL traded up $0.00 during midday trading on Thursday, hitting $0.12. The stock had a trading volume of 154,358 shares, compared to its average volume of 1,181,326. The firm has a market cap of $54.09 million, a price-to-earnings ratio of -11.92 and a beta of 0.89. The company has a 50 day simple moving average of $0.13 and a two-hundred day simple moving average of $0.13. Vivos has a twelve month low of $0.06 and a twelve month high of $0.26.

Vivos Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.